Metformin's Effect on First-Year Weight Gain: A Follow-up Study
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The impact of metformin medication in pregnant women with polycystic ovary syndrome on weight gain during pregnancy and after delivery and the impact on growth of the offspring are essentially unexplored. METHODS: This is a follow-up study of a randomized controlled trial (The Metformin treatment in pregnant PCOS women study), conducted in 11 secondary care centers. Women with PCOS were randomized to metformin (2000 mg daily) or placebo from first trimester to delivery. Questionnaires were sent to 256 participants 1 year postpartum. Maternal weight development in pregnancy and the first year after delivery and offspring anthropometry at birth and weight 1 year postpartum were registered. RESULTS: Women randomized to metformin gained less weight during pregnancy compared with those in the placebo group. In the newborns, there was no difference between the 2 groups in weight or length. One year postpartum, women who used metformin in pregnancy lost less weight and their infants were heavier than those in the placebo group (10.2 ± 1.2 kg vs 9.7 ± 1.1 kg, P = .003). CONCLUSIONS: Women randomized to metformin were heavier in the first trimester, gained less weight in pregnancy, and lost less weight in the first year postpartum compared with women randomized to placebo. Children exposed to metformin weighed more at 1 year of age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)
Rowan, J. A., Rush, E. C., Obolonkin, V., Battin, M., Wouldes, T., & Hague, W. M. (2011) · Diabetes Care · doi:10.2337/dc11-0660 · Cited by 379
Vanky, E., Stridsklev, S., Heimstad, R., Romundstad, P., Skogøy, K., Kleggetveit, O., Hjelle, S., von Brandis, P., Eikeland, T., Flo, K., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0853 · Cited by 315
Self-citationPlacental passage of metformin in women with polycystic ovary syndrome
Vanky, E., Zahlsen, K., Spigset, O., & Carlsen, S. M. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.051 · Cited by 245
Self-citation
Research works printed but not linked: 12
- Begum, 2009, Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome., J Obstet Gynaecol Res, 35, 282, 10.1111/j.1447-0756.2008.00876.x · DOI · Paper page
- Glueck, 2001, Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study., Fertil Steril, 75, 46, 10.1016/S0015-0282(00)01666-6 · DOI · Paper page
- Glueck, 2002, Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin., Hum Reprod, 17, 2858, 10.1093/humrep/17.11.2858 · DOI · Paper page
- Glueck, 2002, Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome., Fertil Steril, 77, 520, 10.1016/S0015-0282(01)03202-2 · DOI · Paper page
- Jakubowicz, 2002, Effects of metformin on early pregnancy loss in the polycystic ovary syndrome., J Clin Endocrinol Metab, 87, 524, 10.1210/jcem.87.2.8207 · DOI · Paper page
- Nawaz, 2008, Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?, J Obstet Gynaecol Res, 34, 832, 10.1111/j.1447-0756.2008.00856.x · DOI · Paper page
- Vanky, 2004, Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study., Hum Reprod, 19, 1734, 10.1093/humrep/deh347 · DOI · Paper page
- Glueck, 2004, Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy., Hum Reprod, 19, 1323, 10.1093/humrep/deh263 · DOI · Paper page
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)., Hum Reprod, 19, 41, 10.1093/humrep/deh098 · DOI · Paper page
- Ibáñez, 2006, Metformin treatment to prevent early puberty in girls with precocious pubarche., J Clin Endocrinol Metab, 91, 2888, 10.1210/jc.2006-0336 · DOI · Paper page
- Ibáñez, 2006, Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: a randomized study in low-birth-weight girls with early-normal onset of puberty., J Clin Endocrinol Metab, 91, 2068, 10.1210/jc.2005-2329 · DOI · Paper page
- Germeyer, 2011, Metformin modulates IL-8, IL-1β, ICAM and IGFBP-1 expression in human endometrial stromal cells., Reprod Biomed Online, 22, 327, 10.1016/j.rbmo.2010.11.006 · DOI
Cited by
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30033-3 · Cited by 767
Pregnancy complications in women with polycystic ovary syndrome
Palomba, S., de Wilde, M. A., Falbo, A., Koster, M. P. H., La Sala, G. B., & Fauser, B. C. J. M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv029 · Cited by 691
“Initial data on metformin administration in pregnant women with PCOS demonstrated a lesser weight gain during pregnancy when compared with controls who received placebo (Vanky et al., 2010; Carlsen et al., 2012), suggesting a potential role of the PCOS-related IR on gestationalweight gain andof themetformin treatment…”
BackgroundRowan, J. A., Rush, E. C., Plank, L. D., Lu, J., Obolonkin, V., Coat, S., & Hague, W. M. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000456 · Cited by 305
Hanem, L. G. E., Stridsklev, S., Júlíusson, P. B., Salvesen, Ø., Roelants, M., Carlsen, S. M., Ødegård, R., & Vanky, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02419 · Cited by 199
Self-citationEpigenetic effects of metformin: from molecular mechanisms to clinical implications
Bridgeman, S. C., Ellison, G. C., Melton, P. E., Newsholme, P., & Mamotte, C. D. S. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13262 · Cited by 190
Metadata
- Authors
- Carlsen, S. M., Martinussen, M. P., & Vanky, E.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2012-11-01
- Volume
- 130
- Issue
- 5
- Pages
- e1222-e1226
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2076148412
- Cited by
- 83
- References
- 3
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metformin's Effect on First-Year Weight Gain: A Follow-up Study. https://app.cochat.ai/papers/10.1542/peds.2012-0346
- The paper
- Carlsen, S. M., Martinussen, M. P., & Vanky, E. (2012). Metformin's Effect on First-Year Weight Gain: A Follow-up Study. Pediatrics. https://doi.org/10.1542/peds.2012-0346
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.